GeneDx Selling And Marketing Expenses vs Cost Of Revenue Analysis

WGSWW Stock

0.15 0.02 11.76%

GeneDx Holdings financial indicator trend analysis is much more than just examining GeneDx Holdings Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GeneDx Holdings Corp is a good investment. Please check the relationship between GeneDx Holdings Selling And Marketing Expenses and its Cost Of Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Selling And Marketing Expenses vs Cost Of Revenue

Selling And Marketing Expenses vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GeneDx Holdings Corp Selling And Marketing Expenses account and Cost Of Revenue. At this time, the significance of the direction appears to have totally related.

The correlation between GeneDx Holdings' Selling And Marketing Expenses and Cost Of Revenue is 0.99. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of GeneDx Holdings Corp, assuming nothing else is changed. The correlation between historical values of GeneDx Holdings' Selling And Marketing Expenses and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of GeneDx Holdings Corp are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Selling And Marketing Expenses i.e., GeneDx Holdings' Selling And Marketing Expenses and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Selling And Marketing Expenses

Cost Of Revenue

Cost of Revenue is found on GeneDx Holdings Corp income statement and represents the costs associated with goods and services GeneDx Holdings provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from GeneDx Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

At this time, GeneDx Holdings' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to climb to about 91.3 M in 2024, whereas Tax Provision is likely to drop (972.3 K) in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	23.4M	63.0M	33.7M	31.3M
Interest Income	79K	2.5M	2.9M	3.1M

Depreciation And Amortization Interest Income

GeneDx Holdings fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Common Stock Shares Outstanding		0.52	0.84	0.32	-0.14	0.5	0.26	-0.69	0.53	-0.85	-0.68	-0.16	0.75	0.71	0.89	-0.09	0.4	-0.5	0.75	-0.8	0.2	0.64	-0.55	0.52	0.44	-0.47
Total Assets	0.52		0.53	0.77	0.53	1.0	0.49	-0.96	-0.3	-0.83	0.14	0.63	0.7	0.25	0.34	0.68	0.25	-1.0	0.69	-0.41	0.91	0.96	-1.0	1.0	0.65	0.41
Short Long Term Debt Total	0.84	0.53		0.35	-0.02	0.55	0.22	-0.71	0.53	-0.84	-0.51	-0.24	0.91	0.51	0.73	-0.14	0.44	-0.53	0.9	-0.94	0.14	0.74	-0.57	0.57	0.25	-0.32
Other Current Liab	0.32	0.77	0.35		0.88	0.76	0.92	-0.79	-0.08	-0.71	0.41	0.31	0.69	-0.26	-0.02	0.31	0.73	-0.82	0.71	-0.46	0.79	0.77	-0.77	0.75	0.07	0.59
Total Current Liabilities	-0.14	0.53	-0.02	0.88		0.54	0.82	-0.48	-0.33	-0.31	0.78	0.36	0.38	-0.66	-0.49	0.33	0.58	-0.59	0.4	-0.11	0.69	0.49	-0.51	0.52	-0.2	0.87
Total Stockholder Equity	0.5	1.0	0.55	0.76	0.54		0.47	-0.96	-0.32	-0.82	0.17	0.63	0.71	0.22	0.3	0.68	0.24	-1.0	0.7	-0.42	0.9	0.96	-1.0	1.0	0.63	0.44
Property Plant And Equipment Net	0.26	0.49	0.22	0.92	0.82	0.47		-0.57	0.16	-0.56	0.33	0.01	0.57	-0.36	-0.07	-0.01	0.89	-0.55	0.6	-0.45	0.55	0.51	-0.48	0.45	-0.21	0.44
Current Deferred Revenue	-0.69	-0.96	-0.71	-0.79	-0.48	-0.96	-0.57		0.03	0.95	0.03	-0.39	-0.86	-0.31	-0.48	-0.46	-0.44	0.96	-0.85	0.64	-0.79	-0.99	0.97	-0.96	-0.55	-0.25
Net Debt	0.53	-0.3	0.53	-0.08	-0.33	-0.32	0.16	0.03		-0.27	-0.7	-0.91	0.39	0.27	0.52	-0.88	0.57	0.29	0.41	-0.7	-0.57	-0.07	0.27	-0.3	-0.41	-0.72
Retained Earnings	-0.85	-0.83	-0.84	-0.71	-0.31	-0.82	-0.56	0.95	-0.27		0.29	-0.12	-0.92	-0.44	-0.67	-0.19	-0.56	0.83	-0.92	0.82	-0.59	-0.92	0.85	-0.83	-0.45	0.03
Accounts Payable	-0.68	0.14	-0.51	0.41	0.78	0.17	0.33	0.03	-0.7	0.29		0.5	-0.19	-0.86	-0.89	0.44	0.04	-0.2	-0.19	0.46	0.44	0.02	-0.11	0.14	-0.27	0.96
Cash	-0.16	0.63	-0.24	0.31	0.36	0.63	0.01	-0.39	-0.91	-0.12	0.5		-0.1	0.02	-0.18	0.99	-0.43	-0.6	-0.11	0.44	0.81	0.4	-0.6	0.61	0.69	0.63
Non Current Assets Total	0.75	0.7	0.91	0.69	0.38	0.71	0.57	-0.86	0.39	-0.92	-0.19	-0.1		0.22	0.51	-0.03	0.69	-0.72	1.0	-0.93	0.41	0.87	-0.73	0.72	0.15	0.02
Non Currrent Assets Other	0.71	0.25	0.51	-0.26	-0.66	0.22	-0.36	-0.31	0.27	-0.44	-0.86	0.02	0.22		0.93	0.09	-0.27	-0.17	0.21	-0.32	-0.02	0.27	-0.27	0.24	0.73	-0.72
Long Term Debt	0.89	0.34	0.73	-0.02	-0.49	0.3	-0.07	-0.48	0.52	-0.67	-0.89	-0.18	0.51	0.93		-0.1	0.1	-0.28	0.5	-0.63	0.01	0.43	-0.36	0.33	0.56	-0.72
Cash And Short Term Investments	-0.09	0.68	-0.14	0.31	0.33	0.68	-0.01	-0.46	-0.88	-0.19	0.44	0.99	-0.03	0.09	-0.1		-0.42	-0.65	-0.04	0.36	0.82	0.46	-0.66	0.67	0.74	0.59
Net Receivables	0.4	0.25	0.44	0.73	0.58	0.24	0.89	-0.44	0.57	-0.56	0.04	-0.43	0.69	-0.27	0.1	-0.42		-0.32	0.71	-0.71	0.17	0.4	-0.27	0.24	-0.44	0.11
Non Current Liabilities Total	-0.5	-1.0	-0.53	-0.82	-0.59	-1.0	-0.55	0.96	0.29	0.83	-0.2	-0.6	-0.72	-0.17	-0.28	-0.65	-0.32		-0.72	0.43	-0.92	-0.96	1.0	-0.99	-0.58	-0.46
Capital Lease Obligations	0.75	0.69	0.9	0.71	0.4	0.7	0.6	-0.85	0.41	-0.92	-0.19	-0.11	1.0	0.21	0.5	-0.04	0.71	-0.72		-0.93	0.41	0.86	-0.72	0.71	0.13	0.03
Inventory	-0.8	-0.41	-0.94	-0.46	-0.11	-0.42	-0.45	0.64	-0.7	0.82	0.46	0.44	-0.93	-0.32	-0.63	0.36	-0.71	0.43	-0.93		-0.07	-0.65	0.45	-0.44	0.02	0.3
Other Current Assets	0.2	0.91	0.14	0.79	0.69	0.9	0.55	-0.79	-0.57	-0.59	0.44	0.81	0.41	-0.02	0.01	0.82	0.17	-0.92	0.41	-0.07		0.77	-0.89	0.88	0.57	0.66
Other Stockholder Equity	0.64	0.96	0.74	0.77	0.49	0.96	0.51	-0.99	-0.07	-0.92	0.02	0.4	0.87	0.27	0.43	0.46	0.4	-0.96	0.86	-0.65	0.77		-0.97	0.97	0.51	0.29
Total Liab	-0.55	-1.0	-0.57	-0.77	-0.51	-1.0	-0.48	0.97	0.27	0.85	-0.11	-0.6	-0.73	-0.27	-0.36	-0.66	-0.27	1.0	-0.72	0.45	-0.89	-0.97		-1.0	-0.64	-0.39
Net Invested Capital	0.52	1.0	0.57	0.75	0.52	1.0	0.45	-0.96	-0.3	-0.83	0.14	0.61	0.72	0.24	0.33	0.67	0.24	-0.99	0.71	-0.44	0.88	0.97	-1.0		0.63	0.41
Property Plant And Equipment Gross	0.44	0.65	0.25	0.07	-0.2	0.63	-0.21	-0.55	-0.41	-0.45	-0.27	0.69	0.15	0.73	0.56	0.74	-0.44	-0.58	0.13	0.02	0.57	0.51	-0.64	0.63		-0.07
Short Long Term Debt	-0.47	0.41	-0.32	0.59	0.87	0.44	0.44	-0.25	-0.72	0.03	0.96	0.63	0.02	-0.72	-0.72	0.59	0.11	-0.46	0.03	0.3	0.66	0.29	-0.39	0.41	-0.07

Click cells to compare fundamentals

GeneDx Holdings Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeneDx Selling And Marketing Expenses vs Cost Of Revenue Analysis

Selling And Marketing Expenses vs Cost Of Revenue

Selling And Marketing Expenses vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Cost Of Revenue

GeneDx Holdings fundamental ratios Correlations

GeneDx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for GeneDx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Capital Lease Obligations	+ 1.0	Non Current Assets Total
Total Liab	+ 1.0	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.99	Cash

Net Invested Capital	- 1.0	Total Liab
Total Liab	- 1.0	Total Stockholder Equity
Non Current Liabilities Total	- 1.0	Total Stockholder Equity
Total Liab	- 1.0	Total Assets
Non Current Liabilities Total	- 1.0	Total Assets
Net Invested Capital	- 0.99	Non Current Liabilities Total